You are here

  • Home
  • Archive
  • Volume 72, Issue 4
  • Is rifabutin prophylaxis against Mycobacterium avium complex infection in HIV infection worthwhile? The net impact on patients suggests not.

Article info

Article menu

This article has a correction. Please see:

Download PDFPDF
Research Article
Is rifabutin prophylaxis against Mycobacterium avium complex infection in HIV infection worthwhile? The net impact on patients suggests not.

Authors

Citation

Stephenson JM, Williams IG
Is rifabutin prophylaxis against Mycobacterium avium complex infection in HIV infection worthwhile? The net impact on patients suggests not.
Sexually Transmitted Infections 1996;72:272-276.
Online issue publication 
March 07, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.